These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 32597562)

  • 1. Nanomedicine Approaches for Advanced Diagnosis and Treatment of Atherosclerosis and Related Ischemic Diseases.
    Hu B; Boakye-Yiadom KO; Yu W; Yuan ZW; Ho W; Xu X; Zhang XQ
    Adv Healthc Mater; 2020 Aug; 9(16):e2000336. PubMed ID: 32597562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Developments in Nanomaterials-Based Drug Delivery and Upgrading Treatment of Cardiovascular Diseases.
    Mohamed NA; Marei I; Crovella S; Abou-Saleh H
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicine for Atherosclerosis: Molecular Imaging and Treatment.
    Karagkiozaki V; Logothetidis S; Pappa AM
    J Biomed Nanotechnol; 2015 Feb; 11(2):191-210. PubMed ID: 26349296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine in the Diagnosis and Treatment of Atherosclerosis-A Systematic Review.
    Vaidyanathan K; Gopalakrishnan S
    Cardiovasc Hematol Disord Drug Targets; 2017; 17(2):119-131. PubMed ID: 28925905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine for Diagnosis and Treatment of Atherosclerosis.
    Cheng J; Huang H; Chen Y; Wu R
    Adv Sci (Weinh); 2023 Dec; 10(36):e2304294. PubMed ID: 37897322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nano-Systems for Advanced Therapeutics and Diagnosis of Atherosclerosis.
    Gaurav C; Saurav B; Goutam R; Goyal AK
    Curr Pharm Des; 2015; 21(30):4498-508. PubMed ID: 26377651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in Managing Atherosclerosis via Nanomedicine.
    Chan CKW; Zhang L; Cheng CK; Yang H; Huang Y; Tian XY; Choi CHJ
    Small; 2018 Jan; 14(4):. PubMed ID: 29239134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherosclerosis and Nanomedicine Potential: Current Advances and Future Opportunities.
    Jiang F; Zhu Y; Gong C; Wei X
    Curr Med Chem; 2020; 27(21):3534-3554. PubMed ID: 30827225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the mechanisms of silica nanoparticles for nanomedicine.
    Li Z; Mu Y; Peng C; Lavin MF; Shao H; Du Z
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1658. PubMed ID: 32602269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis.
    Chen W; Schilperoort M; Cao Y; Shi J; Tabas I; Tao W
    Nat Rev Cardiol; 2022 Apr; 19(4):228-249. PubMed ID: 34759324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances in the Development of Theranostic Nanoparticles for Cardiovascular Diseases.
    Wu Y; Vazquez-Prada KX; Liu Y; Whittaker AK; Zhang R; Ta HT
    Nanotheranostics; 2021; 5(4):499-514. PubMed ID: 34367883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnology translation in vascular diseases: From design to the bench.
    Zhou Y; Yue T; Ding Y; Tan H; Weng J; Luo S; Zheng X
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(1):e1919. PubMed ID: 37548140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecularly targeted nanomedicine enabled by inorganic nanoparticles for atherosclerosis diagnosis and treatment.
    Zhang X; Centurion F; Misra A; Patel S; Gu Z
    Adv Drug Deliv Rev; 2023 Mar; 194():114709. PubMed ID: 36690300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives and opportunities for nanomedicine in the management of atherosclerosis.
    Lobatto ME; Fuster V; Fayad ZA; Mulder WJ
    Nat Rev Drug Discov; 2011 Oct; 10(11):835-52. PubMed ID: 22015921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicine for the prevention, treatment and imaging of atherosclerosis.
    Psarros C; Lee R; Margaritis M; Antoniades C
    Maturitas; 2012 Sep; 73(1):52-60. PubMed ID: 22261366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances of nanomedicine in treatment of atherosclerosis and thrombosis.
    Mao Y; Ren J; Yang L
    Environ Res; 2023 Dec; 238(Pt 2):116637. PubMed ID: 37482129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The upcoming field of theranostic nanomedicine: an overview.
    Prabhu P; Patravale V
    J Biomed Nanotechnol; 2012 Dec; 8(6):859-82. PubMed ID: 23029995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicine for the prevention, treatment and imaging of atherosclerosis.
    Psarros C; Lee R; Margaritis M; Antoniades C
    Nanomedicine; 2012 Sep; 8 Suppl 1():S59-68. PubMed ID: 22640906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticles in nanomedicine: a comprehensive updated review on current status, challenges and emerging opportunities.
    Abdel-Mageed HM; AbuelEzz NZ; Radwan RA; Mohamed SA
    J Microencapsul; 2021 Sep; 38(6):414-436. PubMed ID: 34157915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotechnology-based drug delivery systems for treatment of oral cancer: a review.
    Calixto G; Bernegossi J; Fonseca-Santos B; Chorilli M
    Int J Nanomedicine; 2014; 9():3719-35. PubMed ID: 25143724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.